Ranger Investment Management L.P. Lowers Stake in Stevanato Group S.p.A. $STVN

Ranger Investment Management L.P. decreased its holdings in Stevanato Group S.p.A. (NYSE:STVN) by 2.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,282,175 shares of the company’s stock after selling 38,855 shares during the quarter. Stevanato Group accounts for about 2.3% of Ranger Investment Management L.P.’s investment portfolio, making the stock its 7th largest position. Ranger Investment Management L.P. owned approximately 0.42% of Stevanato Group worth $33,016,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in STVN. Farther Finance Advisors LLC bought a new stake in shares of Stevanato Group during the 3rd quarter valued at $44,000. First Horizon Corp bought a new stake in Stevanato Group during the third quarter valued at about $50,000. State of Wyoming increased its position in Stevanato Group by 39,216.7% in the second quarter. State of Wyoming now owns 2,359 shares of the company’s stock worth $58,000 after buying an additional 2,353 shares in the last quarter. Van Berkom & Associates Inc. lifted its position in shares of Stevanato Group by 50.6% during the 3rd quarter. Van Berkom & Associates Inc. now owns 3,615 shares of the company’s stock valued at $93,000 after buying an additional 1,215 shares in the last quarter. Finally, First Horizon Advisors Inc. grew its stake in shares of Stevanato Group by 14.9% during the 2nd quarter. First Horizon Advisors Inc. now owns 3,833 shares of the company’s stock valued at $94,000 after acquiring an additional 497 shares during the period.

Stevanato Group Stock Up 5.6%

Shares of NYSE STVN opened at €14.95 on Friday. The firm’s 50-day moving average price is €19.97 and its 200-day moving average price is €22.88. The company has a current ratio of 1.89, a quick ratio of 1.30 and a debt-to-equity ratio of 0.26. Stevanato Group S.p.A. has a 12-month low of €13.91 and a 12-month high of €28.00. The stock has a market capitalization of $4.53 billion, a price-to-earnings ratio of 25.98, a P/E/G ratio of 1.24 and a beta of 0.58.

Analysts Set New Price Targets

STVN has been the topic of several analyst reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Stevanato Group in a report on Monday, December 29th. Morgan Stanley began coverage on Stevanato Group in a research report on Monday, December 1st. They issued an “equal weight” rating and a $24.00 price objective on the stock. Finally, Wall Street Zen raised Stevanato Group from a “hold” rating to a “buy” rating in a research note on Friday, January 23rd. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.

Stevanato Group Company Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.